PUBLISHER: TechNavio | PRODUCT CODE: 1908818
PUBLISHER: TechNavio | PRODUCT CODE: 1908818
The global stem cell umbilical cord blood (ucb) market is forecasted to grow by USD 2160.8 mn during 2025-2030, accelerating at a CAGR of 17.9% during the forecast period. The report on the global stem cell umbilical cord blood (ucb) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of hematological disorders and chronic diseases, expansion of regenerative medicine applications, advancements in banking infrastructure and preservation technologies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 17% |
| CAGR | 17.9% |
| Incremental Value | $2160.8 mn |
Technavio's global stem cell umbilical cord blood (ucb) market is segmented as below:
By End-User
By Type
By Application
Geography
This study identifies the emergence and adoption of hybrid and community banking models as one of the prime reasons driving the global stem cell umbilical cord blood (ucb) market growth during the next few years. Also, expansion of clinical indications beyond traditional hematopoietic reconstitution and integration of automated processing and cryopreservation technologies will lead to sizable demand in the market.
The report on the global stem cell umbilical cord blood (ucb) market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global stem cell umbilical cord blood (ucb) market vendors that include Americord Registry LLC, Athersys Inc., CBR Systems Inc., Cells4Life Group LLP, Celularity Inc., Cordlife Group Ltd., Cryo Cell International Inc., Cryoviva Biotech Pvt. Ltd., FamiCord Group, FUTURE CELL JAPAN, Global Cord Blood Corp., LifeCell International Pvt. Ltd., MEDIPOST Co. Ltd., Next Biosciences Pty Ltd., Regrow Biosciences Pvt Ltd., Smart Cells International Ltd., Smith and Nephew plc, STEMCELL Technologies Inc., ViaCord LLC, Vita 34 AG. Also, the global stem cell umbilical cord blood (ucb) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.